BION ENVIRONMENTAL TECHNOLOGIES INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that BION ENVIRONMENTAL TECHNOLOGIES INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Jun 30, 2016 | $3.7K | Sep 26, 2017 |
| FY2016 | Jun 30, 2015 | $3.7K | Sep 19, 2016 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Jun 30, 2015 | $3.7K | Sep 22, 2015 |
| FY2015 | Jun 30, 2014 | $5.9K | Sep 22, 2015 |
| FY2014 | Jun 30, 2013 | $11.9K | Sep 26, 2014 |
| FY2013 | Jun 30, 2012 | $0 | Sep 20, 2013 |
| FY2012 | Jun 30, 2011 | $0 | Sep 25, 2012 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($2.38M) | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | ($11.69M) | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | ($3.19M) | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $8.29M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | ($3.45M) | Sep 27, 2022 |
| FY2016 | Jun 30, 2016 | ($4.52M) | Sep 19, 2016 |
| FY2016 | Jun 30, 2015 | ($5.63M) | Sep 19, 2016 |
| FY2015 | Jun 30, 2014 | ($5.76M) | Sep 22, 2015 |
| FY2014 | Jun 30, 2013 | ($8.24M) | Sep 26, 2014 |
| FY2013 | Jun 30, 2012 | ($6.45M) | Sep 20, 2013 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($2.17M) | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | ($2.07M) | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | ($3.16M) | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | ($2.55M) | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | ($2.83M) | Sep 27, 2022 |
| FY2021 | Jun 30, 2020 | ($4.21M) | Sep 29, 2021 |
| FY2020 | Jun 30, 2019 | ($2.25M) | Sep 22, 2020 |
| FY2019 | Jun 30, 2018 | ($3.52M) | Sep 24, 2019 |
| FY2018 | Jun 30, 2017 | ($2.08M) | Sep 24, 2018 |
| FY2017 | Jun 30, 2016 | ($4.14M) | Sep 26, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $21.7K | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | $23.4K | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | $82.8K | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $200.7K | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $748.5K | Sep 27, 2022 |
| FY2021 | Jun 30, 2020 | $1.12M | Sep 29, 2021 |
| FY2020 | Jun 30, 2019 | $520.1K | Sep 22, 2020 |
| FY2019 | Jun 30, 2018 | $1.19M | Sep 24, 2019 |
| FY2018 | Jun 30, 2017 | $426.0K | Sep 24, 2018 |
| FY2017 | Jun 30, 2016 | $348.6K | Sep 26, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($868.2K) | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | ($849.2K) | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | ($2.93M) | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | ($670.8K) | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | ($1.39M) | Sep 27, 2022 |
| FY2021 | Jun 30, 2020 | ($966.4K) | Sep 29, 2021 |
| FY2020 | Jun 30, 2019 | ($811.1K) | Sep 22, 2020 |
| FY2019 | Jun 30, 2018 | ($467.4K) | Sep 24, 2019 |
| FY2018 | Jun 30, 2017 | ($516.7K) | Sep 24, 2018 |
| FY2017 | Jun 30, 2016 | ($900.0K) | Sep 26, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2024 | $869.4K | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | $3.56M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $2.06M | Sep 28, 2023 |
| FY2020 | Jun 30, 2019 | $2.5K | Sep 22, 2020 |
| FY2018 | Jun 30, 2017 | $1.7K | Sep 24, 2018 |
| FY2017 | Jun 30, 2016 | $5.2K | Sep 26, 2017 |
| FY2015 | Jun 30, 2014 | $850 | Sep 22, 2015 |
| FY2014 | Jun 30, 2013 | $64.2K | Sep 26, 2014 |
| FY2013 | Jun 30, 2012 | $897.2K | Sep 20, 2013 |
| FY2012 | Jun 30, 2011 | $6.41M | Sep 25, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $29.2K | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | $112.3K | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | $7.59M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $6.36M | Sep 28, 2023 |
| FY2022 | Dec 29, 2021 | $0 | Sep 27, 2022 |
| FY2023 | Sep 30, 2021 | $297 | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $4.34M | Sep 27, 2022 |
| FY2021 | Jun 30, 2020 | $571.2K | Sep 29, 2021 |
| FY2020 | Jun 30, 2019 | $53.0K | Sep 22, 2020 |
| FY2019 | Jun 30, 2018 | $31.9K | Sep 24, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $7.13M | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | $5.88M | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | $3.36M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $7.25M | Sep 28, 2023 |
| FY2023 | Dec 29, 2021 | $10.23M | Sep 28, 2023 |
| FY2023 | Sep 30, 2021 | $10.15M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $15.75M | Sep 27, 2022 |
| FY2021 | Jun 30, 2020 | $15.66M | Sep 29, 2021 |
| FY2020 | Jun 30, 2019 | $14.73M | Sep 22, 2020 |
| FY2019 | Jun 30, 2018 | $13.73M | Sep 24, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($7.13M) | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | ($5.81M) | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | $4.19M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | ($932.2K) | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | ($11.45M) | Sep 27, 2022 |
| FY2021 | Jun 30, 2020 | ($15.13M) | Sep 29, 2021 |
| FY2020 | Jun 30, 2019 | ($14.72M) | Sep 22, 2020 |
| FY2019 | Jun 30, 2018 | ($13.75M) | Sep 24, 2019 |
| FY2018 | Jun 30, 2017 | ($15.18M) | Sep 24, 2018 |
| FY2017 | Jun 30, 2016 | ($13.94M) | Sep 26, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($141.31M) | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | ($138.93M) | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | ($127.24M) | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | ($124.05M) | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | ($132.34M) | Sep 27, 2022 |
| FY2021 | Jun 30, 2020 | ($128.89M) | Sep 29, 2021 |
| FY2020 | Jun 30, 2019 | ($124.35M) | Sep 22, 2020 |
| FY2019 | Jun 30, 2018 | ($121.69M) | Sep 24, 2019 |
| FY2018 | Jun 30, 2017 | ($118.68M) | Sep 24, 2018 |
| FY2017 | Jun 30, 2016 | ($116.22M) | Sep 26, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Jun 30, 2019 | $41.3K | Sep 24, 2019 |
| FY2019 | Jun 30, 2018 | $22.0K | Sep 24, 2019 |
| FY2019 | Jun 30, 2017 | $72.9K | Sep 24, 2019 |
| FY2018 | Jun 30, 2016 | $170.2K | Sep 24, 2018 |
| FY2017 | Jun 30, 2015 | $339.3K | Sep 26, 2017 |
| FY2016 | Jun 30, 2014 | $186.1K | Sep 19, 2016 |
| FY2015 | Jun 30, 2013 | $44.7K | Sep 22, 2015 |
| FY2014 | Jun 30, 2012 | $400.0K | Sep 26, 2014 |
| FY2013 | Jun 30, 2011 | $1.39M | Sep 20, 2013 |
| FY2012 | Jun 30, 2010 | $1.03M | Sep 25, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Sep 28, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Sep 28, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 56.68M | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | 56.52M | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | 47.34M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | 43.05M | Sep 28, 2023 |
| FY2021 | Jun 30, 2021 | 40.61M | Sep 29, 2021 |
| FY2021 | Jun 30, 2020 | 30.70M | Sep 29, 2021 |
| FY2021 | Jun 30, 2019 | 27.36M | Sep 29, 2021 |
| FY2020 | Jun 30, 2018 | 25.24M | Sep 22, 2020 |
| FY2019 | Jun 30, 2017 | 24.04M | Sep 24, 2019 |
| FY2018 | Jun 30, 2016 | 22.87M | Sep 24, 2018 |